Natriumchlorid Fresenius Kabi (Sodium Chloride)

Sodium chloride provides Na⁺ and Cl⁻ ions that increase plasma osmolality, drawing water into the vascular compartment. This expands intravascular volume, corrects hyponatremia, supports nerve and muscle function, and helps maintain acid‑base equilibrium. The isotonic formulation matches physiological saline, allowing safe volume expansion without causing cellular swelling.

The prescribed dose of Natriumchlorid Fresenius Kabi is determined by the treating physician based on the patient’s fluid deficit, electrolyte status, and clinical condition. Dosage is individualized and may be administered as a bolus or continuous infusion, with the rate adjusted according to laboratory monitoring and therapeutic response.

Sodium chloride is a naturally occurring electrolyte, and replacement therapy is often required in pregnancy and lactation when fluid loss occurs. However, safety information is limited, and the decision to use Natriumchlorid Fresenius Kabi should be made by a healthcare professional after evaluating the potential benefits and risks for both mother and infant.

To place an order, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details—including any cold‑chain requirements—and assists with import documentation.

Natriumchlorid Fresenius Kabi is an isotonic sodium chloride solution comparable to standard 0.9 % saline. Its composition matches physiological electrolyte concentrations, offering predictable volume expansion. Compared with hypertonic or hypotonic preparations, it provides a balanced approach for routine fluid replacement without the added risk of rapid shifts in serum sodium.

The product should be stored at ambient temperature, protected from direct sunlight and moisture, and kept in its original sealed container until use. Do not freeze the solution. Before administration, inspect the vial for particulate matter or discoloration and ensure aseptic technique during preparation.

Natriumchlorid Fresenius Kabi can be given intravenously, intramuscularly, or subcutaneously according to the clinical need. Intravenous infusion is the most common route, delivered through a sterile infusion set or syringe. The administration rate is set by the prescriber and may be adjusted based on patient response and laboratory results.

The most serious risks include severe hypernatremia, fluid overload leading to pulmonary edema or heart failure exacerbation, and rare allergic reactions such as anaphylaxis. Prompt monitoring of serum electrolytes, fluid balance, and clinical signs is essential to detect and manage these complications early.

Natriumchlorid should be used with caution or avoided in patients with uncontrolled congestive heart failure, severe renal impairment, or known hypersensitivity to sodium chloride solutions. In such cases, alternative fluid management strategies may be more appropriate, and the decision should be guided by a qualified healthcare professional.